Pregled bibliografske jedinice broj: 1088779
Pediatric anti-n-methyl-d-aspartate receptor encephalitis: case series
Pediatric anti-n-methyl-d-aspartate receptor encephalitis: case series // 37th Annual Meeting of the European Society for Paediatric Infectious Diseases
Ljubljana, Slovenija, 2019. (poster, međunarodna recenzija, neobjavljeni rad, ostalo)
CROSBI ID: 1088779 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pediatric anti-n-methyl-d-aspartate receptor
encephalitis: case series
Autori
Krajcar, Nina ; Stemberger Marić, Lorna ; Roglić, Srđan ; Tešović, Goran
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, neobjavljeni rad, ostalo
Skup
37th Annual Meeting of the European Society for Paediatric Infectious Diseases
Mjesto i datum
Ljubljana, Slovenija, 06.05.2019. - 11.05.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
anti‐NMDAR encephalitis ; children
Sažetak
Background Anti–N‐methyl‐D‐aspartate receptor (anti‐ NMDAR) encephalitis is a severe form of encephalitis with specific neurological features that is increasingly recognized in children and adolescents worldwide. In the pediatric population symptoms are similar to those in adults, but seizures, behavioral changes and movement disorders are more prominent and occurrence of underlying tumor is lower. We describe clinical features and treatment outcomes of seven children with anti‐NMDAR encephalitis treated at University Hospital for Infectious Diseases in Zagreb. Case Presentation Summary A total of 7 children were treated between September 2012 and September 2018. The median age was 9 years and 8 months (range 10 months-17 years) ; 5 of them were female. All cases presented with seizures, depressed level of consciousness and movement disorder ; insomnia was observed in 85% ; behavioural changes, memory deficits and hallucinations in 71% ; autonomic instability and language dysfunction in 57% of cases. The diagnosis was confirmed by positive anti-NMDAR antibodies (serum and CSF). Three patients required mechanical ventilation (duration 4-14 days). No patient had a tumor. One infant had a biphasic disease with HSV encephalitis followed by NMDAR encephalitis (22 days after). Although one patient had clinical improvement after corticosteroids, others (after initial immunoglobulins/total plasma exchange therapy) were treated with second-line therapies: cyclophosphamide (n=5) and rituximab (n=2). All children had substantial recovery ; relapses were not observed. Learning Points/Discussion Our case series outlines common clinical features of pediatric anti‐NMDAR encephalitis. Good clinical outcomes were observed in all children after first or second-line treatment ; full recovery with only minor deficits were present in more than half of the cases. This disorder is likely under-recognized and should be suspected in children with neuropsychiatric deficits because early recognition and prompt treatment are essential to obtain full recovery in these patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Lorna Stemberger Marić
(autor)
Nina Krajcar
(autor)
Goran Tešović
(autor)
Srđan Roglić
(autor)